What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

In this study, we aimed to compare the engraftment days, graft versus host disease (GVHD) development, relapse and overall survival (OS) rates in patients using variable intensity conditioning regimens with two different post-transplant cyclophosphamide (PTCy) doses for hematological malignancies. W...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transfusion and apheresis science 2025-02, Vol.64 (1), p.104058, Article 104058
Hauptverfasser:	Ulas, Turgay, Namdaroglu, Sinem, Hindilerden, Ipek Yonal, Erkurt, Mehmet Ali, Erer, Kerim, Yigenoglu, Tugce Nur, Tiryaki, Tarik Onur, Hidayet, Emine, Korkmaz, Serdal, Ulu, Bahar Uncu, Yilmaz, Seda, Kaya, Emin, Pepeler, Mehmet Sezgin, Basturk, Abdulkadir, Dal, Mehmet Sinan, Altuntas, Fevzi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Cyclophosphamide - administration & dosage Cyclophosphamide - therapeutic use Female Graft vs Host Disease - prevention & control Hematologic neoplasms Hematologic Neoplasms - therapy Hematopoietic stem cell transplantation Hematopoietic Stem Cell Transplantation - methods Humans Male Middle Aged Posttransplant cyclophosphamide Retrospective Studies Transplantation Conditioning - methods Transplantation, Homologous - methods Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!